Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer Research
|
December 16, 2000
K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression
S Guerrero, I Casanova, L Farré, et al.
Oncogene
|
October 31, 1998
NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity
R Mangues, T Corral, S Lu, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia
R Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Revista De Medicina De La Universidad De Navarra
|
June 1, 1984
[Requirements in parenteral nutrition. Design and preparation of the diets]
J Giráldez, G Cajaraville, M J Tamés, et al.
Oncogene
|
March 20, 1997
Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas
M Malumbres, I Pérez de Castro, J Santos, et al.
Cancer Research
|
March 27, 1998
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice
R Mangues, T Corral, N E Kohl, et al.
Cellular Signalling
|
January 7, 1998
S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ
P Dent, Y Wang, Y Z Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
M Esteller, S González, R A Risques, et al.
Chemical Communications (Cambridge, England)
|
March 22, 2017
The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles
L Sánchez-García, N Serna, M Mattanovich, et al.
Carcinogenesis
|
June 15, 2012
Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
M A Pavón, M Parreño, M Téllez-Gabriel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer Research
|
December 16, 2000
K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression
S Guerrero, I Casanova, L Farré, et al.
Oncogene
|
October 31, 1998
NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity
R Mangues, T Corral, S Lu, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia
R Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Revista De Medicina De La Universidad De Navarra
|
June 1, 1984
[Requirements in parenteral nutrition. Design and preparation of the diets]
J Giráldez, G Cajaraville, M J Tamés, et al.
Oncogene
|
March 20, 1997
Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas
M Malumbres, I Pérez de Castro, J Santos, et al.
Cancer Research
|
March 27, 1998
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice
R Mangues, T Corral, N E Kohl, et al.
Cellular Signalling
|
January 7, 1998
S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ
P Dent, Y Wang, Y Z Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
M Esteller, S González, R A Risques, et al.
Chemical Communications (Cambridge, England)
|
March 22, 2017
The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles
L Sánchez-García, N Serna, M Mattanovich, et al.
Carcinogenesis
|
June 15, 2012
Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
M A Pavón, M Parreño, M Téllez-Gabriel, et al.
Page
of 2